首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
1-PHENYL-3-PIPERAZINE-PYRAZOLES AND PESTICIDAL COMPOSITIONS OF MATTER THEREOF
摘要
申请公布号
EP1841744(A1)
申请公布日期
2007.10.10
申请号
EP20050819854
申请日期
2005.12.02
申请人
MERIAL LIMITED
发明人
SCHNATTERER, STEFAN;MAIER, MICHAEL;PETRY, FRIEDERIKE;KNAUF, WERNER;SEEGER, KARL
分类号
C07D231/44;A01N43/56;A01N43/60;A01N43/62;A61K31/4155;A61K31/496;A61K31/506;A61K31/551;C07D401/12;C07D403/04;C07D403/12
主分类号
C07D231/44
代理机构
代理人
主权项
地址
您可能感兴趣的专利
IMPROVED APPARATUS AND PROCESS FOR SEPARATING ALUMINIUM FROM A MIXTURE OF ALUMINIUM AND ALUMINIUM DROSS
AMPHIPHILIC POLYAMINE COMPOUNDS
FIBER OPTIC ADAPTER, INCLUDING HYBRID CONNECTOR SYSTEM
PHARMACEUTICAL COMPOUNDS FOR THE INHIBITION OF HEPATITIS C VIRUS NS3 PROTEASE
SERVICE DELIVERY IN A MOBILE COMMUNICATIONS SYSTEM SUPPORTING TWO CONNECTION TYPES
METHOD FOR PRODUCING PYRIMIDOPTERIDINES
QUINOLINE AND QUINOXALINE COMPOUNDS AS PDGF-RECEPTOR AND/OR LCK TYROSINE KINASE INHIBITORS
DNA ENCODING PROTEINS THAT INHIBIT Hsp70 FUNCTION
NOVEL POLYETHER POLYOLS BASED ON TRIAZOLE GROUP CONTAINING COMPOUNDS AND A PROCESS FOR THEIR PRODUCTION
CHRYSTALS OF 5-[{6-(2-FLUOROBENZYL)OXY-2-NAPHTHYL}METHYL]-2,4-THIAZOLIDINEDIONE
NOVEL ACYLGUANIDINE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CRYSTAL MODIFICATION B OF 8-CYANO-1- CYCLOPROPYL -7-(1S,6S-2, 8-DIAZABICYCLO [4.3.0]NONAN -8-YL)-6- FLUORO-1,4- DIHYDRO-4- OXO-3-QUINOLINE CARBOXYLIC ACID
RADICAL-CURABLE ADHESIVE COMPOSITIONS, REACTION PRODUCTS OF WHICH DEMONSTRATE SUPERIOR RESISTANCE TO THERMAL DEGRADATION
NOVEL GENE ENCODING BRAIN-SPECIFIC MEMBRANE PROTEIN
AIR INTERFACE BASED WIRELESS TELECOMMUNICATION TEST SYSTEM
A COMMUNICATION SIGNAL RECEIVER AND AN OPERATING METHOD THEREFOR
HIGH SOLIDS, PUMPABLE AQUEOUS COMPOSITIONS OF HIGH MONOALKYL PHOSPHATE ESTER SALT CONTENT
CURABLE COMPOSITIONS COMPRISING ACETOACETOXY AND IMINE FUNCTIONALITY
PEPTIDES THAT MODULATE THE INTERACTION OF B CLASS EPHRINS AND PDZ DOMAINS
INJECTABLE ANTHELMINTIC FORMULATION